Breztri® Aerosphere is a prescription maintenance treatment used for the prevention of chronic obstructive pulmonary disease (COPD) flare-ups in adults.
Key Features:
– Contains a combination of three active ingredients: budesonide (an anti-inflammatory corticosteroid), glycopyrrolate (a long-acting muscarinic antagonist or LAMA), and formoterol fumarate (a long-acting beta2-agonist or LABA)
– Administered as an inhalation aerosol via metered dose inhaler using innovative co-suspension delivery technology
– Provides triple action to open airways, reduce inflammation, and clear mucus from lungs
– Twice daily dosing helps maintain lung function and improve breathing
– Built-in dose indicator, ergonomic shape, and short inhalation period
Dosage: 2 inhalations twice daily at the same time every day, approximately 12 hours apart
Storage: Store at room temperature between 68°F to 77°F; with cap on, protect from moisture. Safety clip prevents accidental actuation.
Warnings: Not for relief of sudden breathing problems from COPD flare-ups. May increase risks of pneumonia, osteoporosis, glaucoma or cataracts.




Reviews
There are no reviews yet.